6/20/2011 | BKCVHY | S&P assigns Endo loan BBB-, notes BB-
|
6/7/2011 | HY | Market Commentary: Freescale drive-by, Symbion, Norske Skog price; Arch, Teleflex ahead; Sino-Forest sours again
|
6/6/2011 | HY | Market Commentary: Primary slacks off with no new pricings; market awaits Symbion; Sino-Forest gyrates; Compton up
|
6/3/2011 | HY | New Issue: Endo Pharmaceuticals prices upsized $900 million two-part senior notes
|
6/3/2011 | HY | Market Commentary: Vulcan mega-deal, Endo, W&T price to end short week; Sino-Forest chopped down after report
|
5/31/2011 | HY | Endo Pharmaceuticals sets structure for $700 million senior notes
|
5/31/2011 | HY | Market Commentary: Cinemark, Puget drive-bys price in quiet post-holiday market; Arch, Vulcan slate mega-deals
|
5/27/2011 | HY | Market Commentary: Market winds down before holiday; recent deals see demand; McClatchy firms on asset sale
|
5/26/2011 | BKCVHYIG | S&P cuts Endo, rates loan BBB- and notes BB-
|
5/26/2011 | HY | Endo Pharmaceuticals to start roadshow Tuesday for $700 million notes
|
5/26/2011 | HY | Market Commentary: GM, WCA, Oil States, International Auto price, move up; Endo, W&T slate; funds up $94 million
|
5/26/2011 | BKCVHY | Moody's rates Endo loan Ba1, notes Ba3
|
4/14/2011 | BKHY | Endo plans $2.9 billion facility, $700 million bonds for AMS purchase
|
4/11/2011 | BKHY | Endo plans term loans and bonds for purchase of American Medical
|
4/11/2011 | BKHY | S&P puts Endo on watch
|
4/11/2011 | HY | Market Commentary: Vail, Spencer price; hospital bonds hit on Tenet suit; Level 3, Global Crossing up on deal
|
4/11/2011 | BKCVHY | Endo looking to deleverage after American Medical Systems acquisition
|
4/11/2011 | BKCVHY | Moody's may cut Endo notes
|
4/11/2011 | BKCVHY | S&P: American Medical Systems unchanged
|
11/19/2010 | HY | Market Commentary: Petco, upsized Paetec price, both rise to close out $10 billion week; secondary slide resumes
|
11/18/2010 | HY | New Issue: Endo Pharmaceuticals prices $400 million 7% 10-year notes at 99.105 to yield 7 1/8%
|
11/15/2010 | HY | Endo Pharmaceuticals to price $400 million 10-year notes Thursday
|
11/15/2010 | HY | Moody's rates Endo notes Ba2
|
11/15/2010 | HY | Market Commentary: Ally $1 billion drive-by leads $2.4 billion session, falls in trading; GM gains as IPO looms
|
10/5/2009 | HYPV | Endo buys $48 million of Ledgemont's 16% notes in tender offer
|